Last reviewed · How we verify
Methicillin-Resistant Staphylococcus Aureus Nasal Colonization
Approved treatments
- Bactroban · GSK
Bactroban works by inhibiting the production of essential proteins in bacteria, preventing them from reproducing and causing infection.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Methicillin-Resistant Staphylococcus Aureus Nasal Colonization patent landscape — cliff calendar, originator estates, attackable patents
- Methicillin-Resistant Staphylococcus Aureus Nasal Colonization treatment landscape brief
- Methicillin-Resistant Staphylococcus Aureus Nasal Colonization treatment updates RSS
Frequently asked questions about Methicillin-Resistant Staphylococcus Aureus Nasal Colonization
What drugs treat Methicillin-Resistant Staphylococcus Aureus Nasal Colonization?
Tracked treatments include Bactroban.
What is the treatment for Methicillin-Resistant Staphylococcus Aureus Nasal Colonization?
Standard treatment for Methicillin-Resistant Staphylococcus Aureus Nasal Colonization includes Bactroban. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Methicillin-Resistant Staphylococcus Aureus Nasal Colonization patent cliff · Methicillin-Resistant Staphylococcus Aureus Nasal Colonization CI report
- Treatment: Bactroban · GSK
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing